These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6393673)

  • 1. Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases.
    Bonora E; Orioli S; Coscelli C; Buzzelli G; Gentilini P; Butturini U
    Acta Diabetol Lat; 1984; 21(3):241-50. PubMed ID: 6393673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Active chronic hepatitis and insulin resistance: possible role of glucagon, GH and free fatty acids].
    Bonora E; Coscelli C; Orioli S; Cambi R; Buzzelli G; Gentilini P; Butturini U
    G Clin Med; 1981 Dec; 62(12):831-45. PubMed ID: 7042433
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin and somatotropic hormone secretion and connective tissue function in patients with chronic hepatitis and liver cirrhosis].
    Okorokov AN
    Ter Arkh; 1984; 56(2):67-71. PubMed ID: 6369610
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired plasma amino-acid clearance in patients with cirrhosis of the liver and portocaval shunt--its relation to insulin resistance.
    Ferenci P; Bratusch-Marrain P; Waldhäusl WK; Nowotny P; Korn A
    Eur J Clin Invest; 1984 Aug; 14(4):255-61. PubMed ID: 6434319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
    Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
    J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.
    Busch-Sørensen M; Holst JJ; Lyngsøe J
    J Endocrinol Invest; 1991 Jan; 14(1):25-30. PubMed ID: 1675225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon, insulin, cortisol, and growth hormone levels following major surgery: their relationship to glucose and free fatty acid elevations.
    Göschke H; Bär E; Girard J; Leutenegger A; Niederer W; Oberholzer M; Wolff G
    Horm Metab Res; 1978 Nov; 10(6):465-70. PubMed ID: 744565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance in liver diseases].
    Petrides AS; Strohmeyer G
    Z Gastroenterol; 1986 Aug; 24(8):403-15. PubMed ID: 3532594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex variations in free fatty acids and ketones during fasting: evidence for a role of glucagon.
    Merimee TJ; Misbin RI; Pulkkinen AJ
    J Clin Endocrinol Metab; 1978 Mar; 46(3):414-9. PubMed ID: 752030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
    Nørrelund H; Nielsen S; Christiansen JS; Jørgensen JO; Møller N
    Eur J Endocrinol; 2004 Jun; 150(6):779-87. PubMed ID: 15191347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man.
    Hicks BH; Taylor CI; Vij SK; Pek S; Knopf RF; Floyd JC; Fajans SS
    Metabolism; 1977 Sep; 26(9):1011-23. PubMed ID: 895532
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucagon levels and metabolic effects in fasting man.
    Marliss EB; Aoki TT; Unger RH; Soeldner JS; Cahill GF
    J Clin Invest; 1970 Dec; 49(12):2256-70. PubMed ID: 5480852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.
    Bonora E; Cigolini M; Bosello O; Zancanaro C; Capretti L; Zavaroni I; Coscelli C; Butturini U
    Curr Med Res Opin; 1984; 9(1):47-51. PubMed ID: 6373159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of carbohydrate metabolism in postnecrotic cirrhosis liver.
    Yeung RT; Wang CC
    Gut; 1974 Nov; 15(11):907-12. PubMed ID: 4455570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on glucose, amino acid and protein metabolism in patients with liver cirrhosis in relation to plasma levels of human growth hormone (author's transl)].
    Ogura C
    Hokkaido Igaku Zasshi; 1975 Sep; 50(5):489-506. PubMed ID: 815150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hormone and metabolite concentrations in plasma of steers during a prolonged fast.
    Rule DC; Beitz DC; de Boer G; Lyle RR; Trenkle AH; Young JW
    J Anim Sci; 1985 Oct; 61(4):868-75. PubMed ID: 3905737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.